Trends in Birth Weight and Gestational Age for Infants Born to HIV-infected, Antiretroviral Treatment-Naïve Women in Malawi
Published Date:May 2012
Source:Pediatr Infect Dis J. 31(5):481-486.
Infant, Low Birth Weight
Infant, Premature, Diseases
Infectious Disease Transmission, Vertical
Pregnancy Complications, Infectious
Pubmed Central ID:PMC3329585
Funding:#5R03TW01199/TW/FIC NIH HHS/United States
5-U50-PS022061-05/PS/NCHHSTP CDC HHS/United States
N01-AI-35173-117/AI/NIAID NIH HHS/United States
N01-CP-33005/CP/NCI NIH HHS/United States
P01-AI-26499/AI/NIAID NIH HHS/United States
R03 TW001199/TW/FIC NIH HHS/United States
R03 TW001199-01/TW/FIC NIH HHS/United States
R03 TW001199-01S1/TW/FIC NIH HHS/United States
R03 TW001199-02/TW/FIC NIH HHS/United States
R03 TW001199-03/TW/FIC NIH HHS/United States
R03 TW001199-04/TW/FIC NIH HHS/United States
R03 TW001199-05/TW/FIC NIH HHS/United States
R03 TW001199-06/TW/FIC NIH HHS/United States
R21-AI-33874-01/AI/NIAID NIH HHS/United States
R24 HD042854/HD/NICHD NIH HHS/United States
U01 AI048005/AI/NIAID NIH HHS/United States
U01 AI048005-01/AI/NIAID NIH HHS/United States
U01 AI048005-02/AI/NIAID NIH HHS/United States
U01 AI048005-03/AI/NIAID NIH HHS/United States
U01 AI048005-04/AI/NIAID NIH HHS/United States
U01 AI048005-05/AI/NIAID NIH HHS/United States
U01 AI048005-05S1/AI/NIAID NIH HHS/United States
U01 AI048005-05S2/AI/NIAID NIH HHS/United States
U01 AI048005-05S3/AI/NIAID NIH HHS/United States
U01 AI048005-05S4/AI/NIAID NIH HHS/United States
U01-AI-48005/AI/NIAID NIH HHS/United States
U50-CC0222061/CC/ODCDC CDC HHS/United States
We analyzed birth outcomes among infants of treatment-naïve, HIV-infected women from a series of mother-to-child transmission of HIV studies in Blantyre, Malawi.
Data from six prospective studies at one research site were analyzed. Mean birth weight (BW) and gestational age (GA), and frequency of low birth weight (LBW; <2500 g) and preterm (PT) birth (GA<37 weeks) were estimated. We assessed risk factors for LBW and PT birth using mixed-effects logistic regression. Adjusted odds ratios (AOR) and 95% confidence intervals (CI) from earlier studies (1989-94) and later studies (2000-07) are presented separately.
The analysis included 8874 HIV-exposed infants. Mean BW and GA ranged from 2793 to 3079 g, and 37.8 to 39.0 weeks. Greater maternal age was consistently (during both the early and late periods) associated with lower odds of LBW and PT birth; AOR (95% CI) for both outcomes in the early and late periods, respectively, were 0.98 (0.96-1.00) and 0.97 (0.95-0.99). Female infant gender was consistently associated with higher odds of PT birth during both periods and with higher odds of LBW during the later period. During the early period, higher maternal education was associated with lower odds of LBW (AOR 0.67 (0.48-0.95)) and PT birth (AOR 0.70 (0.51-0.95)) and later birth year was associated with lower odds of PT birth (AOR 0.35 (0.19-0.70)).
BW and GA remained stable within each time period. This analysis provides important baseline information for monitoring HIV treatment effects on birth outcomes. Modifiable factors affecting BW and GA should continue to be explored.
application/vnd.ms-powerpoint text/plain image/gif image/jpeg
You May Also Like: